DK1666057T3 - Fremgangsmåde til fremstilling af en acellulær vaccine indeholdende Bordetella pertussis antigener - Google Patents

Fremgangsmåde til fremstilling af en acellulær vaccine indeholdende Bordetella pertussis antigener

Info

Publication number
DK1666057T3
DK1666057T3 DK04018329T DK04018329T DK1666057T3 DK 1666057 T3 DK1666057 T3 DK 1666057T3 DK 04018329 T DK04018329 T DK 04018329T DK 04018329 T DK04018329 T DK 04018329T DK 1666057 T3 DK1666057 T3 DK 1666057T3
Authority
DK
Denmark
Prior art keywords
preparing
bordetella pertussis
vaccine containing
pertussis antigens
acellular vaccine
Prior art date
Application number
DK04018329T
Other languages
Danish (da)
English (en)
Inventor
Pavel Novotny
Original Assignee
Medeva Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10656410&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1666057(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Medeva Bv filed Critical Medeva Bv
Application granted granted Critical
Publication of DK1666057T3 publication Critical patent/DK1666057T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/099—Bordetella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Liquid Crystal Substances (AREA)
DK04018329T 1989-05-08 1990-04-26 Fremgangsmåde til fremstilling af en acellulær vaccine indeholdende Bordetella pertussis antigener DK1666057T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898910570A GB8910570D0 (en) 1989-05-08 1989-05-08 Acellular vaccine

Publications (1)

Publication Number Publication Date
DK1666057T3 true DK1666057T3 (da) 2009-06-08

Family

ID=10656410

Family Applications (3)

Application Number Title Priority Date Filing Date
DK96112324T DK0747058T3 (da) 1989-05-08 1990-04-26 Acellulær vaccine
DK04018329T DK1666057T3 (da) 1989-05-08 1990-04-26 Fremgangsmåde til fremstilling af en acellulær vaccine indeholdende Bordetella pertussis antigener
DK90907222T DK0471726T4 (da) 1989-05-08 1990-04-26 Acellulær vaccine

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK96112324T DK0747058T3 (da) 1989-05-08 1990-04-26 Acellulær vaccine

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK90907222T DK0471726T4 (da) 1989-05-08 1990-04-26 Acellulær vaccine

Country Status (12)

Country Link
US (1) US7479283B1 (fr)
EP (3) EP1666057B1 (fr)
JP (2) JP3281369B2 (fr)
AT (3) ATE276759T1 (fr)
DE (14) DE69034264D1 (fr)
DK (3) DK0747058T3 (fr)
ES (3) ES2322352T3 (fr)
FR (1) FR09C0033I1 (fr)
GB (1) GB8910570D0 (fr)
LU (15) LU90204I2 (fr)
NL (13) NL980007I1 (fr)
WO (1) WO1990013313A1 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8412207D0 (en) * 1984-05-12 1984-06-20 Wellcome Found Antigenic preparations
GB8910570D0 (en) 1989-05-08 1989-06-21 Wellcome Found Acellular vaccine
EP0484621A3 (en) * 1990-07-11 1992-08-26 American Cyanamid Company Efficacious vaccines against bordetella pertussis comprising a combination of individually purified pertussis antigens
GB9021004D0 (en) * 1990-09-27 1990-11-07 Wellcome Found Acellular vaccines
GB9209118D0 (en) * 1992-04-28 1992-06-10 Sb 120 Amsterdam Bv Vaccine compositions
FR2754543B1 (fr) * 1996-10-11 1998-12-31 Pasteur Institut Souche de bordetella deficiente dans la production de toxine et exprimant une proteine hydride, liposomes comprenant de la fha et leurs utilisations comme vaccins, et utilisation de la fha pour stimuler les reponses immunitaires
US7022522B2 (en) 1998-11-13 2006-04-04 Limin Guan Macroporous polymer scaffold containing calcium phosphate particles
RU2148412C1 (ru) * 1999-08-06 2000-05-10 Москаленко Екатерина Петровна Способ получения протективного коклюшного антигена
DE602004028262D1 (de) * 2003-10-02 2010-09-02 Glaxosmithkline Biolog Sa B. pertussis antigene und ihre verwendung bei der vakzinierung
US8877201B2 (en) * 2007-10-25 2014-11-04 Wake Forest University Health Sciences Bordetella outer-membrane protein antigens and methods of making and using the same
EP2250144A4 (fr) 2008-03-07 2014-06-04 Arkema Inc Systèmes formulés et stables contenant du chloro-3,3,3-trifluoropropène
GB201105981D0 (en) 2011-04-08 2011-05-18 Glaxosmithkline Biolog Sa Novel process
AP2015008702A0 (en) 2013-03-08 2015-09-30 Crucell Holland Bv Acellular pertussis vaccine
RU2662968C2 (ru) 2013-09-08 2018-07-31 Пфайзер Инк. Иммуногенная композиция против neisseria meningitidis (варианты)
AU2016221318B2 (en) 2015-02-19 2020-06-25 Pfizer Inc. Neisseria meningitidis compositions and methods thereof

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2047886A1 (en) 1969-06-30 1971-03-19 Merieux Inst Non-toxic anti-whooping cough vaccine
EP0043349B1 (fr) 1980-06-27 1987-08-12 Ciba-Geigy Ag Agents synergiques et procédé pour combattre sélectivement les mauvaises herbes, particulièrement dans les cultures de céréales et de soya
JPS5750925A (en) 1980-09-12 1982-03-25 Takeda Chem Ind Ltd Preparation of pertussis toxoid
JPS58222032A (ja) 1982-06-18 1983-12-23 Teijin Ltd 百日咳毒素のサブユニツト蛋白
US5237052A (en) * 1984-05-12 1993-08-17 Burroughs Wellcome Company Antigenic preparations and isolation of such preparations
GB8412207D0 (en) 1984-05-12 1984-06-20 Wellcome Found Antigenic preparations
JPS6176422A (ja) * 1984-09-22 1986-04-18 Chemo Sero Therapeut Res Inst 百日ぜきコンポ−ネントワクチンおよび百日ぜき・ジフテリア・破傷風混合ワクチンの製造方法
FR2590483B1 (fr) 1985-11-22 1988-12-09 Pasteur Institut Antigenes purifies ayant des proprietes vaccinantes contre b. pertussis, moyens notamment adns recombinants pour les produire et compositions de vaccins les contenant
GB8601279D0 (en) * 1986-01-20 1986-02-26 Public Health Lab Service Purification of pertussis antigens
EP0267498B1 (fr) * 1986-11-11 1993-01-27 Siemens Aktiengesellschaft Transformateur de courant à flux compensé
EP0267998A1 (fr) * 1986-11-17 1988-05-25 Institut Pasteur Moyens de protection contre l'infection et l'intoxication par bordetella
FR2606789B1 (fr) 1986-11-17 1991-05-31 Pasteur Institut Preparations d'adenylate cyclase purifiees, procede d'obtention de ces preparations et leurs applications biologiques
US5358868A (en) * 1987-11-24 1994-10-25 Connaught Laboratories Limited Genetic detoxification of pertussis toxin
GB8807860D0 (en) 1988-04-05 1988-05-05 Connaught Lab Pertussis vaccine
US5101014A (en) * 1989-02-10 1992-03-31 United States Of America Process for the purification of a 69,000 da outer membrane protein of Bordetella pertussis
US5162223A (en) * 1989-02-17 1992-11-10 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Resources Hybridomas and resulting monoclonal antibodies directed against antigens of Bordetella pertussis
GB8910570D0 (en) 1989-05-08 1989-06-21 Wellcome Found Acellular vaccine
US5276142A (en) * 1989-12-11 1994-01-04 American Cyanamid Company Process for purification of a 69000 dalton antigenic protein from Bordetella pertussis
GB9007416D0 (en) 1990-04-02 1990-05-30 Wellcome Found Expression of heterologous protein in yeast
GB9007657D0 (en) 1990-04-04 1990-05-30 Connaught Lab Purification of a pertussis outer membrane protein(omp69)
IT1248735B (it) 1990-06-21 1995-01-26 Sclavo Spa Vaccini acellulari contro la pertosse
EP0484621A3 (en) 1990-07-11 1992-08-26 American Cyanamid Company Efficacious vaccines against bordetella pertussis comprising a combination of individually purified pertussis antigens
US6051240A (en) 1994-04-28 2000-04-18 Takeda Chemical Industries, Ltd. Method of separating protective components of Bordetella pertussis
US5972225A (en) * 1996-05-07 1999-10-26 Cook Imaging Corporation Process for remediating endotoxin-contaminated bulk non-ionic contrast media

Also Published As

Publication number Publication date
NL300400I1 (en) 2009-10-01
DE122005000020I1 (de) 2005-06-23
NL300183I1 (nl) 2005-06-01
DK0471726T3 (da) 1997-03-03
JP2002226397A (ja) 2002-08-14
JP3281369B2 (ja) 2002-05-13
ES2230555T3 (es) 2005-05-01
DE122005000019I1 (de) 2005-06-23
ATE147271T1 (de) 1997-01-15
WO1990013313A1 (fr) 1990-11-15
DK0471726T4 (da) 2008-09-15
NL300187I1 (nl) 2005-06-01
LU91154I2 (fr) 2005-06-23
NL300403I1 (en) 2009-10-01
EP1666057A2 (fr) 2006-06-07
LU91149I2 (fr) 2005-06-23
NL300185I1 (nl) 2005-06-01
EP1666057A3 (fr) 2008-06-04
ATE422900T1 (de) 2009-03-15
DE69034166D1 (de) 2004-10-28
EP0471726B2 (fr) 2008-05-14
EP0471726A1 (fr) 1992-02-26
DE69034166T2 (de) 2005-08-04
LU91595I2 (fr) 2009-10-12
NL300189I1 (nl) 2005-06-01
LU91151I2 (fr) 2005-06-23
LU91597I2 (fr) 2009-10-12
EP0747058A1 (fr) 1996-12-11
DE122005000018I1 (de) 2005-06-23
GB8910570D0 (en) 1989-06-21
LU91150I2 (fr) 2005-06-23
DK0747058T3 (da) 2005-01-10
DE69029656T2 (de) 1997-04-24
NL300404I1 (en) 2009-10-01
DE122009000042I1 (de) 2009-11-05
DE122009000043I1 (de) 2009-11-05
NL300401I1 (en) 2009-10-01
LU91152I2 (fr) 2005-06-23
NL300402I1 (en) 2009-10-01
EP1666057B1 (fr) 2009-02-18
DE122009000044I1 (de) 2009-11-05
LU91153I2 (fr) 2005-06-23
LU91592I2 (fr) 2009-10-12
EP0747058B1 (fr) 2004-09-22
NL980007I1 (nl) 1998-04-01
ES2095874T5 (es) 2008-11-01
EP0471726B1 (fr) 1997-01-08
US7479283B1 (en) 2009-01-20
NL300184I1 (nl) 2005-06-01
DE122005000017I1 (de) 2005-06-23
DE122005000015I1 (de) 2005-11-24
ATE276759T1 (de) 2004-10-15
NL300186I1 (nl) 2005-06-01
FR09C0033I1 (fr) 2009-09-25
DE122009000041I1 (de) 2009-11-05
NL300188I1 (nl) 2005-06-01
LU91591I2 (fr) 2009-10-12
DE69029656D1 (de) 1997-02-20
LU90204I2 (fr) 1998-04-06
LU91596I2 (fr) 2009-10-12
DE122005000016I1 (de) 2005-06-23
DE69034264D1 (de) 2009-04-02
DE69029656T3 (de) 2009-06-04
ES2095874T3 (es) 1997-03-01
LU91594I2 (fr) 2009-10-12
LU91593I2 (fr) 2009-10-12
JPH04505158A (ja) 1992-09-10
DE122005000014I1 (de) 2005-06-23
LU91155I2 (fr) 2005-06-23
ES2322352T3 (es) 2009-06-19

Similar Documents

Publication Publication Date Title
NL300400I1 (en) Method and manufacture of an acellular vaccine comprising Bordetella pertussis antigens
ATE61937T1 (de) Antigenische zubereitungen und isolierung von solchen zubereitungen.
EP0563288A4 (en) Immunopotentiation of vaccines, particularly swine pleuropneumonia vaccines